Products / Onchology y Oncohematology

Gezt

Gemcitabine 200-1000 mg

Gemcitabine is indicated for the treatment of locally advanced or metastatic bladder cancer, in combination with cisplatin. It is also indicated for the treatment of patients locally advanced or metastatic adenocarcinoma of the pancreas, and as first line treatment of patients with non-microcytic lung cancer.

Therapeutic Action

Antineoplastic

Presentations

1 vial

Gezt Gemcitabine 200-1000 mg de Laboratorios Richmond
Download Prospect

Legal Notice

Products which continue to have a valid patent protection at present are manufactured in line with the current laws of the Argentine Republic. Please, take into account that our products will only be shipped to countries where the substance and its use are not protected by patents.

Laboratorios Richmond S.A.C.I.F. Argentina © All rights reserved Terms of use

NOTICE The legal content included on this site was designed exclusively to meet the needs of the health-care professionals for the adequate use of the pharmaceutical products. It does not contain promotional information. All the texts referring to our prescription products are compliant with the guidelines approved by ANMAT, the Argentine administration for drugs, food and medical technology. Laboratorios Richmond always recommends consulting a qualified health-care professional if you have doubts regarding any given medical

I understand and wish to see the information